Search

everythinglearnresearchcommunity

for

Search:↓

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

The inhibitor affects androgen metabolism but not ovarian function.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Scalp microinfusion with dutasteride is a safe and promising treatment for male hair loss.

Vitamin D receptor is essential for healthy bones and skin.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Zusanli acupoint injection of metoclopramide effectively treats functional dyspepsia.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Microneedle technology is effective for skin rejuvenation and enhancing cosmeceutical delivery, with ongoing innovation and increasing commercialization.

New niosomal formulation effectively delivers aminexil through rat skin.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

Mesotherapy is a minimally invasive treatment with potential benefits and risks, requiring standardized practices and further investigation.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Niosomes are a promising and effective way to deliver drugs through the skin.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Mesotherapy with dutasteride improves hair growth and reduces symptoms in frontal fibrosing alopecia.

A brain-made hormone can protect against memory-related brain damage caused by harmful proteins.

Enriching the French health care database with external data greatly improved its usefulness.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.